-
Sanofi plots 670 layoffs in France as local tensions brew
fiercepharma
December 10, 2018
Sanofi may be on the up-and-up thanks to its vaccines unit and new anti-inflammatory star Dupixent, but the company still intends to shed more than 600 jobs in its home country over the next couple of years.
-
NIHR streams £5m into global infectious diseases research
pharmatimes
November 19, 2018
The National Institute for Health Research is streaming £5 million of global health funding into research looking at how infectious diseases spread
-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
Is Moderna prepping for biotech's biggest-ever IPO?
fiercebiotech
September 14, 2018
Modera Therapeutics is one of a select group of biotech "unicorns."
-
ImmusanT to develop Type 1 diabetes vaccine with JDRF backing
fiercebiotech
September 12, 2018
JDRF plans to do more than just support ImmusanT with a VC investment, and will engage in a collaboration on the project.
-
A Review of the Vaccines Marketed in China: 63 Varieties of Vaccines from 45 Enterprises
1℃
August 10, 2018
The vaccine incident of Changsheng Bio-technology has continued to simmer recently. Vaccine fabrication is something absolutely intolerable.
-
Online information on vaccines and autism not always reliable, study shows
worldpharmanews
June 20, 2018
Research at Brighton and Sussex Medical School (BSMS) has found that information available online can provide unreliable information based on old, 'weak' scientific studies. The study 'Fake news or weak science?' is published in open-access journal Fronti
-
Sanofi Pasteur and Translate Bio to develop new mRNA vaccines
pharmaceutical-technology
June 13, 2018
Global vaccine company Sanofi Pasteur has signed a research and development (R&D) collaboration and exclusive licensing agreement with therapeutics company Translate Bio to develop new vaccines using mRNA technology.
-
Sri Lanka to register two foreign cancer vaccines
biospectrumasia
June 08, 2018
The Russian vaccine ‘Hearticad’ which was brought down by the minister was rejected by the Sri Lanka College of Oncologists.